data |
array (
'code' => 0,
'params' =>
array (
'keyword' => '批件',
'page' => 1,
),
'page_size' => 20,
'page_count' => 1.0,
'count' => 13,
'is_fuzzy' => true,
'rows' =>
array (
0 =>
array (
'id' => '47762',
'title' => '中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床批件',
'keywords' => '生物,研究,临床,活疫苗,中国,变异,奥密,国家,批件,国家药监局,国药,集团,病毒,安全,生物制品,制品,疫苗,研究所,香港,免疫',
'description' => '感谢IT之家网友 航空先生 的线索投递!IT之家 4 月 26 日消息,国药集团中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床批件。国药集团中国生物在前期已上市原型株新冠灭活疫苗和完成贝塔、德',
'catid' => '7',
'title_highlight' => '中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床<em>批件</em>',
'content' => '...生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床<em>批件</em>。国药集团中国生物在前期已上市原型株新冠灭活疫苗和完成贝塔、德尔塔变异株灭活疫苗研发的基础上,第一时间从香港大学引进奥密克戎变异毒株,2021 年 12 月 9 ...',
'keywords_highlight' => '生物,研究,临床,活疫苗,中国,变异,奥密,国家,<em>批件</em>,国家药监局,国药,集团,病毒,安全,生物制品,制品,疫苗,研究所,香港,免疫',
'description_highlight' => '感谢IT之家网友 航空先生 的线索投递!IT之家 4 月 26 日消息,国药集团中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床<em>批件</em>。国药集团中国生物在前期已上市原型株新冠灭活疫苗和完成贝塔、德',
'inputtime' => '1651774397',
'updatetime' => '1651774397',
'thumb' => NULL,
'url' => '/youxi-47762',
'tags' =>
array (
0 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
1 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
2 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
3 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
4 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
5 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
6 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
7 =>
array (
'key' => '国家',
'url' => 'https://www.dh3g.com/s-国家',
),
8 =>
array (
'key' => '批件',
'url' => 'https://www.dh3g.com/s-批件',
),
9 =>
array (
'key' => '国家药监局',
'url' => 'https://www.dh3g.com/s-国家药监局',
),
10 =>
array (
'key' => '国药',
'url' => 'https://www.dh3g.com/s-国药',
),
11 =>
array (
'key' => '集团',
'url' => 'https://www.dh3g.com/s-集团',
),
12 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
13 =>
array (
'key' => '安全',
'url' => 'https://www.dh3g.com/s-安全',
),
14 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
15 =>
array (
'key' => '制品',
'url' => 'https://www.dh3g.com/s-制品',
),
16 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
17 =>
array (
'key' => '研究所',
'url' => 'https://www.dh3g.com/s-研究所',
),
18 =>
array (
'key' => '香港',
'url' => 'https://www.dh3g.com/s-香港',
),
19 =>
array (
'key' => '免疫',
'url' => 'https://www.dh3g.com/s-免疫',
),
),
),
1 =>
array (
'id' => '46196',
'title' => '中国生物两款新冠病毒奥密克戎灭活疫苗获香港临床批件',
'keywords' => '生物,研究,活疫苗,病毒,中国,香港,临床,疫苗,冠状,生物制品,制品,研究所,伦理,免疫,批件,奥密,之家,大学,北京,武汉',
'description' => '感谢IT之家网友 深圳靓仔、Jack张宇航 的线索投递!IT之家 4 月 18 日消息,据中国生物发布,近日,由国药集团中国生物北京生物制品研究所、武汉生物制品研究所研发的两款新型冠状病毒灭活疫苗(奥',
'catid' => '7',
'title_highlight' => '中国生物两款新冠病毒奥密克戎灭活疫苗获香港临床<em>批件</em>',
'content' => '...会的审查同意,以及香港药剂业及毒药管理局的临床试验<em>批件</em>,正式获准在香港开展新冠疫苗的序贯免疫临床研究。中国生物所属北京生物制品研究所、武汉生物制品研究所开展科研攻关,研发了 BIBP-新型冠状病毒灭活疫苗(O ...',
'keywords_highlight' => '生物,研究,活疫苗,病毒,中国,香港,临床,疫苗,冠状,生物制品,制品,研究所,伦理,免疫,<em>批件</em>,奥密,之家,大学,北京,武汉',
'description_highlight' => '感谢IT之家网友 深圳靓仔、Jack张宇航 的线索投递!IT之家 4 月 18 日消息,据中国生物发布,近日,由国药集团中国生物北京生物制品研究所、武汉生物制品研究所研发的两款新型冠状病毒灭活疫苗(奥',
'inputtime' => '1651773522',
'updatetime' => '1651773522',
'thumb' => NULL,
'url' => '/youxi-46196',
'tags' =>
array (
0 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
1 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
2 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
3 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
4 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
5 =>
array (
'key' => '香港',
'url' => 'https://www.dh3g.com/s-香港',
),
6 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
7 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
8 =>
array (
'key' => '冠状',
'url' => 'https://www.dh3g.com/s-冠状',
),
9 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
10 =>
array (
'key' => '制品',
'url' => 'https://www.dh3g.com/s-制品',
),
11 =>
array (
'key' => '研究所',
'url' => 'https://www.dh3g.com/s-研究所',
),
12 =>
array (
'key' => '伦理',
'url' => 'https://www.dh3g.com/s-伦理',
),
13 =>
array (
'key' => '免疫',
'url' => 'https://www.dh3g.com/s-免疫',
),
14 =>
array (
'key' => '批件',
'url' => 'https://www.dh3g.com/s-批件',
),
15 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
16 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
17 =>
array (
'key' => '大学',
'url' => 'https://www.dh3g.com/s-大学',
),
18 =>
array (
'key' => '北京',
'url' => 'https://www.dh3g.com/s-北京',
),
19 =>
array (
'key' => '武汉',
'url' => 'https://www.dh3g.com/s-武汉',
),
),
),
2 =>
array (
'id' => '43962',
'title' => '康希诺新冠 mRNA 疫苗已获国家药品监督管理局药物临床试验批件',
'keywords' => '疫苗,临床,试验,生物,中国,开发,变异,国产,平台,技术,已获,希诺,重要,中国澳门,之家,企业,医药,我国,方面,中国香港',
'description' => '感谢IT之家网友 深圳靓仔 的线索投递!IT之家 4 月 4 日消息,康希诺生物今日发布公告称,其开发的新型冠状病毒 mRNA 疫苗已获得国家药品监督管理局药物临床试验批件。康希诺生物解释称,相较于传',
'catid' => '7',
'title_highlight' => '康希诺新冠 mRNA 疫苗已获国家药品监督管理局药物临床试验<em>批件</em>',
'content' => '...状病毒 mRNA 疫苗已获得国家药品监督管理局药物临床试验<em>批件</em>。康希诺生物解释称,相较于传统疫苗技术平台,mRNA 技术产业化平台在研发工艺和生产周期等方面都有显著优势,对标该领域位居前沿的国际生物医药企业,建成后...',
'keywords_highlight' => '疫苗,临床,试验,生物,中国,开发,变异,国产,平台,技术,已获,希诺,重要,中国澳门,之家,企业,医药,我国,方面,中国香港',
'description_highlight' => '感谢IT之家网友 深圳靓仔 的线索投递!IT之家 4 月 4 日消息,康希诺生物今日发布公告称,其开发的新型冠状病毒 mRNA 疫苗已获得国家药品监督管理局药物临床试验<em>批件</em>。康希诺生物解释称,相较于传',
'inputtime' => '1651772272',
'updatetime' => '1651772272',
'thumb' => NULL,
'url' => '/youxi-43962',
'tags' =>
array (
0 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
1 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
2 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
3 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
4 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
5 =>
array (
'key' => '开发',
'url' => 'https://www.dh3g.com/s-开发',
),
6 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
7 =>
array (
'key' => '国产',
'url' => 'https://www.dh3g.com/s-国产',
),
8 =>
array (
'key' => '平台',
'url' => 'https://www.dh3g.com/s-平台',
),
9 =>
array (
'key' => '技术',
'url' => 'https://www.dh3g.com/s-技术',
),
10 =>
array (
'key' => '已获',
'url' => 'https://www.dh3g.com/s-已获',
),
11 =>
array (
'key' => '希诺',
'url' => 'https://www.dh3g.com/s-希诺',
),
12 =>
array (
'key' => '重要',
'url' => 'https://www.dh3g.com/s-重要',
),
13 =>
array (
'key' => '中国澳门',
'url' => 'https://www.dh3g.com/s-中国澳门',
),
14 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
15 =>
array (
'key' => '企业',
'url' => 'https://www.dh3g.com/s-企业',
),
16 =>
array (
'key' => '医药',
'url' => 'https://www.dh3g.com/s-医药',
),
17 =>
array (
'key' => '我国',
'url' => 'https://www.dh3g.com/s-我国',
),
18 =>
array (
'key' => '方面',
'url' => 'https://www.dh3g.com/s-方面',
),
19 =>
array (
'key' => '中国香港',
'url' => 'https://www.dh3g.com/s-中国香港',
),
),
),
3 =>
array (
'id' => '47017',
'title' => '张文宏:奥密克戎疫苗已获批临床试验,将很快面世',
'keywords' => '疫苗,临床,生物,中国,奥密,国家,香港,研究,张文,试验,批件,活疫苗,病毒,很快,生物制品,传染病,制品,国药,研究所,论坛',
'description' => '更新:《中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床批件》IT之家 4 月 22 日消息,据证券之声报道,4 月 21 日,在博鳌亚洲论坛 2022 年年会上,国家传染病医学中心主任张文宏在',
'catid' => '7',
'title_highlight' => '张文宏:奥密克戎疫苗已获批临床试验,将很快面世',
'content' => '...生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床<em>批件</em>》IT之家 4 月 22 日消息,据证券之声报道,4 月 21 日,在博鳌亚洲论坛 2022 年年会上,国家传染病医学中心主任张文宏在论坛中指出,目前,奥密克戎疫苗已经获批进...',
'keywords_highlight' => '疫苗,临床,生物,中国,奥密,国家,香港,研究,张文,试验,<em>批件</em>,活疫苗,病毒,很快,生物制品,传染病,制品,国药,研究所,论坛',
'description_highlight' => '更新:《中国生物奥密克戎变异株新冠病毒灭活疫苗获国家药监局临床<em>批件</em>》IT之家 4 月 22 日消息,据证券之声报道,4 月 21 日,在博鳌亚洲论坛 2022 年年会上,国家传染病医学中心主任张文宏在',
'inputtime' => '1651773976',
'updatetime' => '1651773976',
'thumb' => NULL,
'url' => '/youxi-47017',
'tags' =>
array (
0 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
1 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
2 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
3 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
4 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
5 =>
array (
'key' => '国家',
'url' => 'https://www.dh3g.com/s-国家',
),
6 =>
array (
'key' => '香港',
'url' => 'https://www.dh3g.com/s-香港',
),
7 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
8 =>
array (
'key' => '张文',
'url' => 'https://www.dh3g.com/s-张文',
),
9 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
10 =>
array (
'key' => '批件',
'url' => 'https://www.dh3g.com/s-批件',
),
11 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
12 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
13 =>
array (
'key' => '很快',
'url' => 'https://www.dh3g.com/s-很快',
),
14 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
15 =>
array (
'key' => '传染病',
'url' => 'https://www.dh3g.com/s-传染病',
),
16 =>
array (
'key' => '制品',
'url' => 'https://www.dh3g.com/s-制品',
),
17 =>
array (
'key' => '国药',
'url' => 'https://www.dh3g.com/s-国药',
),
18 =>
array (
'key' => '研究所',
'url' => 'https://www.dh3g.com/s-研究所',
),
19 =>
array (
'key' => '论坛',
'url' => 'https://www.dh3g.com/s-论坛',
),
),
),
4 =>
array (
'id' => '49670',
'title' => '全球首支奥密克戎变异株新冠病毒灭活疫苗临床试验第一针在杭州完成接种',
'keywords' => '临床,疫苗,研究,变异,奥密,病毒,试验,活疫苗,批件,生物,中国,杭州,人群,伦理,国家,时间,药物,生物制品,以下简称,传染性',
'description' => 'IT之家 5 月 2 日消息,据中国青年报报道,5 月 1 日,由国药集团中国生物北京生物制品研究所研发的奥密克戎变异株(以下简称奥株)新冠病毒灭活疫苗临床研究,正式在浙江省杭州市完成第一剂接种。这是',
'catid' => '7',
'title_highlight' => '全球首支奥密克戎变异株新冠病毒灭活疫苗临床试验第一针在杭州完成接种',
'content' => '...苗研发,并于 2022 年 4 月 26 日获得国家药监局临床试验<em>批件</em>。获得临床<em>批件</em>后,树兰(杭州)医院国家药物临床试验机构立即开展项目启动前的准备工作,在最短的时间内完成药物临床试验伦理委员会审查获得伦理<em>批件</em>,临床...',
'keywords_highlight' => '临床,疫苗,研究,变异,奥密,病毒,试验,活疫苗,<em>批件</em>,生物,中国,杭州,人群,伦理,国家,时间,药物,生物制品,以下简称,传染性',
'description_highlight' => 'IT之家 5 月 2 日消息,据中国青年报报道,5 月 1 日,由国药集团中国生物北京生物制品研究所研发的奥密克戎变异株(以下简称奥株)新冠病毒灭活疫苗临床研究,正式在浙江省杭州市完成第一剂接种。这是',
'inputtime' => '1651775026',
'updatetime' => '1651775026',
'thumb' => NULL,
'url' => '/youxi-49670',
'tags' =>
array (
0 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
1 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
2 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
3 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
4 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
5 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
6 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
7 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
8 =>
array (
'key' => '批件',
'url' => 'https://www.dh3g.com/s-批件',
),
9 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
10 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
11 =>
array (
'key' => '杭州',
'url' => 'https://www.dh3g.com/s-杭州',
),
12 =>
array (
'key' => '人群',
'url' => 'https://www.dh3g.com/s-人群',
),
13 =>
array (
'key' => '伦理',
'url' => 'https://www.dh3g.com/s-伦理',
),
14 =>
array (
'key' => '国家',
'url' => 'https://www.dh3g.com/s-国家',
),
15 =>
array (
'key' => '时间',
'url' => 'https://www.dh3g.com/s-时间',
),
16 =>
array (
'key' => '药物',
'url' => 'https://www.dh3g.com/s-药物',
),
17 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
18 =>
array (
'key' => '以下简称',
'url' => 'https://www.dh3g.com/s-以下简称',
),
19 =>
array (
'key' => '传染性',
'url' => 'https://www.dh3g.com/s-传染性',
),
),
),
5 =>
array (
'id' => '47484',
'title' => '7 个月,销售易用“中国速度”向世界 500 强证明国产 CRM 软实力',
'keywords' => '中国,速度,销售,系统,时间,世界,公司,数据,开发,服务,品牌,同时,外企,市场,软件,需求,国产,实力,业务,功能',
'description' => '有一种速度叫"中国速度"。世界最快高铁"复兴号",最高运行速度可达 400km / h,平均时速 350km / h。有着"中国新四大发明"之一的高铁正在向全世界展示"中国速度"。从立项开始,76 天',
'catid' => '7',
'title_highlight' => '7 个月,销售易用“中国速度”向世界 500 强证明国产 CRM 软实力',
'content' => '...正在向全世界展示"中国速度"。从立项开始,76 天获临床<em>批件</em>,169 天获得生产许可证,374 天获得附条件上市<em>批件</em>,1 年时间完成超 20 亿剂年产能构建,实现全球供应超 27 亿剂。中国科兴用令人瞩目的疫苗速度印证了"中国速度"...',
'keywords_highlight' => '中国,速度,销售,系统,时间,世界,公司,数据,开发,服务,品牌,同时,外企,市场,软件,需求,国产,实力,业务,功能',
'description_highlight' => '有一种速度叫"中国速度"。世界最快高铁"复兴号",最高运行速度可达 400km / h,平均时速 350km / h。有着"中国新四大发明"之一的高铁正在向全世界展示"中国速度"。从立项开始,76 天',
'inputtime' => '1651774237',
'updatetime' => '1651774237',
'thumb' => NULL,
'url' => '/youxi-47484',
'tags' =>
array (
0 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
1 =>
array (
'key' => '速度',
'url' => 'https://www.dh3g.com/s-速度',
),
2 =>
array (
'key' => '销售',
'url' => 'https://www.dh3g.com/s-销售',
),
3 =>
array (
'key' => '系统',
'url' => 'https://www.dh3g.com/s-系统',
),
4 =>
array (
'key' => '时间',
'url' => 'https://www.dh3g.com/s-时间',
),
5 =>
array (
'key' => '世界',
'url' => 'https://www.dh3g.com/s-世界',
),
6 =>
array (
'key' => '公司',
'url' => 'https://www.dh3g.com/s-公司',
),
7 =>
array (
'key' => '数据',
'url' => 'https://www.dh3g.com/s-数据',
),
8 =>
array (
'key' => '开发',
'url' => 'https://www.dh3g.com/s-开发',
),
9 =>
array (
'key' => '服务',
'url' => 'https://www.dh3g.com/s-服务',
),
10 =>
array (
'key' => '品牌',
'url' => 'https://www.dh3g.com/s-品牌',
),
11 =>
array (
'key' => '同时',
'url' => 'https://www.dh3g.com/s-同时',
),
12 =>
array (
'key' => '外企',
'url' => 'https://www.dh3g.com/s-外企',
),
13 =>
array (
'key' => '市场',
'url' => 'https://www.dh3g.com/s-市场',
),
14 =>
array (
'key' => '软件',
'url' => 'https://www.dh3g.com/s-软件',
),
15 =>
array (
'key' => '需求',
'url' => 'https://www.dh3g.com/s-需求',
),
16 =>
array (
'key' => '国产',
'url' => 'https://www.dh3g.com/s-国产',
),
17 =>
array (
'key' => '实力',
'url' => 'https://www.dh3g.com/s-实力',
),
18 =>
array (
'key' => '业务',
'url' => 'https://www.dh3g.com/s-业务',
),
19 =>
array (
'key' => '功能',
'url' => 'https://www.dh3g.com/s-功能',
),
),
),
6 =>
array (
'id' => '89147',
'title' => '中国生物人凝血因子 Ⅷ 上市,可用于防治血友病等',
'keywords' => '药品,生物,因子,天坛,天坛生物,产品,管理局,生产,监督,中国,之家,企业,公司,制品,国家,官方,消息,球蛋白,血液,血液制品',
'description' => 'IT之家 9 月 10 日消息 根据国药集团中国生物官方消息,今日其下属企业天坛生物发布公告称,近日收到国家药品监督管理局签发的《药品注册证书》,成都蓉生研制的"人凝血因子 Ⅷ"符合药品注册的有关要求',
'catid' => '7',
'title_highlight' => '中国生物人凝血因子 Ⅷ 上市,可用于防治血友病等',
'content' => '...pH4),也获得国家药品监督管理局颁发的《药物临床试验<em>批件</em>》,批准开展临床试验。该产品能够特异性治疗新冠肺炎。',
'keywords_highlight' => '药品,生物,因子,天坛,天坛生物,产品,管理局,生产,监督,中国,之家,企业,公司,制品,国家,官方,消息,球蛋白,血液,血液制品',
'description_highlight' => 'IT之家 9 月 10 日消息 根据国药集团中国生物官方消息,今日其下属企业天坛生物发布公告称,近日收到国家药品监督管理局签发的《药品注册证书》,成都蓉生研制的"人凝血因子 Ⅷ"符合药品注册的有关要求',
'inputtime' => '1651811540',
'updatetime' => '1651811540',
'thumb' => NULL,
'url' => '/youxi-89147',
'tags' =>
array (
0 =>
array (
'key' => '药品',
'url' => 'https://www.dh3g.com/s-药品',
),
1 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
2 =>
array (
'key' => '因子',
'url' => 'https://www.dh3g.com/s-因子',
),
3 =>
array (
'key' => '天坛',
'url' => 'https://www.dh3g.com/s-天坛',
),
4 =>
array (
'key' => '天坛生物',
'url' => 'https://www.dh3g.com/s-天坛生物',
),
5 =>
array (
'key' => '产品',
'url' => 'https://www.dh3g.com/s-产品',
),
6 =>
array (
'key' => '管理局',
'url' => 'https://www.dh3g.com/s-管理局',
),
7 =>
array (
'key' => '生产',
'url' => 'https://www.dh3g.com/s-生产',
),
8 =>
array (
'key' => '监督',
'url' => 'https://www.dh3g.com/s-监督',
),
9 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
10 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
11 =>
array (
'key' => '企业',
'url' => 'https://www.dh3g.com/s-企业',
),
12 =>
array (
'key' => '公司',
'url' => 'https://www.dh3g.com/s-公司',
),
13 =>
array (
'key' => '制品',
'url' => 'https://www.dh3g.com/s-制品',
),
14 =>
array (
'key' => '国家',
'url' => 'https://www.dh3g.com/s-国家',
),
15 =>
array (
'key' => '官方',
'url' => 'https://www.dh3g.com/s-官方',
),
16 =>
array (
'key' => '消息',
'url' => 'https://www.dh3g.com/s-消息',
),
17 =>
array (
'key' => '球蛋白',
'url' => 'https://www.dh3g.com/s-球蛋白',
),
18 =>
array (
'key' => '血液',
'url' => 'https://www.dh3g.com/s-血液',
),
19 =>
array (
'key' => '血液制品',
'url' => 'https://www.dh3g.com/s-血液制品',
),
),
),
7 =>
array (
'id' => '105085',
'title' => '智飞生物:重组新冠疫苗(CHO 细胞)对奥密克戎变异株依然有效',
'keywords' => '疫苗,变异,生物,奥密,重组,抗体,研究,之家,受试者,微生物,消息,疫情,研究所,血清,阳性,微生,临床,检测,试验,生物制品',
'description' => 'IT之家 12 月 13 日消息,据智飞生物官网消息,针对奥密克戎变异株,重组新冠疫苗仍然可以提供很好的保护。由中科院微生物研究所组织开展的研究结果发现:78% 受试者血清对奥密克戎变异株中和抗体检测',
'catid' => '7',
'title_highlight' => '智飞生物:重组新冠疫苗(CHO 细胞)对奥密克戎变异株依然有效',
'content' => '...重组亚单位新冠疫苗。2020 年 6 月,该疫苗获得临床试验<em>批件</em>,2020 年 11 月,海外启动国际 Ⅲ 期临床试验。2021 年 3 月 10 日,该疫苗获批紧急使用,这是全球首个获批使用的重组蛋白新冠疫苗,助力了国内外的疫情防控工作。',
'keywords_highlight' => '疫苗,变异,生物,奥密,重组,抗体,研究,之家,受试者,微生物,消息,疫情,研究所,血清,阳性,微生,临床,检测,试验,生物制品',
'description_highlight' => 'IT之家 12 月 13 日消息,据智飞生物官网消息,针对奥密克戎变异株,重组新冠疫苗仍然可以提供很好的保护。由中科院微生物研究所组织开展的研究结果发现:78% 受试者血清对奥密克戎变异株中和抗体检测',
'inputtime' => '1651820462',
'updatetime' => '1651820462',
'thumb' => NULL,
'url' => '/youxi-105085',
'tags' =>
array (
0 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
1 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
2 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
3 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
4 =>
array (
'key' => '重组',
'url' => 'https://www.dh3g.com/s-重组',
),
5 =>
array (
'key' => '抗体',
'url' => 'https://www.dh3g.com/s-抗体',
),
6 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
7 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
8 =>
array (
'key' => '受试者',
'url' => 'https://www.dh3g.com/s-受试者',
),
9 =>
array (
'key' => '微生物',
'url' => 'https://www.dh3g.com/s-微生物',
),
10 =>
array (
'key' => '消息',
'url' => 'https://www.dh3g.com/s-消息',
),
11 =>
array (
'key' => '疫情',
'url' => 'https://www.dh3g.com/s-疫情',
),
12 =>
array (
'key' => '研究所',
'url' => 'https://www.dh3g.com/s-研究所',
),
13 =>
array (
'key' => '血清',
'url' => 'https://www.dh3g.com/s-血清',
),
14 =>
array (
'key' => '阳性',
'url' => 'https://www.dh3g.com/s-阳性',
),
15 =>
array (
'key' => '微生',
'url' => 'https://www.dh3g.com/s-微生',
),
16 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
17 =>
array (
'key' => '检测',
'url' => 'https://www.dh3g.com/s-检测',
),
18 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
19 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
),
),
8 =>
array (
'id' => '48829',
'title' => '中国生物:新的奥密克戎新冠灭活疫苗有望在 9 月底上市(附最新全面解答)',
'keywords' => '疫苗,变异,临床,云涛,中国,研究,生物,奥密,免疫,人群,病毒,活疫苗,原型,速度,国药,我国,效果,活性,群体,保护',
'description' => 'IT之家 4 月 29 日消息,据央视新闻一加一报道,国药集团中国生物首席科学家张云涛表示,"中国生物针对奥密克戎灭活疫苗什么时候能够上市,取决于我们的临床研究速度,就是安全性、有效性获得的速度,临床',
'catid' => '7',
'title_highlight' => '中国生物:新的奥密克戎新冠灭活疫苗有望在 9 月底上市(附最新全面解答)',
'content' => '...奥株)新冠病毒灭活疫苗全国首个获国家药监局临床试验<em>批件</em>,引发社会各界广泛关注。应社会关切和媒体采访需求,中国生物于 4 月 27 日以视频会议方式召开媒体沟通会,向社会公众通报有关情况,对大家所关心的问题进行...',
'keywords_highlight' => '疫苗,变异,临床,云涛,中国,研究,生物,奥密,免疫,人群,病毒,活疫苗,原型,速度,国药,我国,效果,活性,群体,保护',
'description_highlight' => 'IT之家 4 月 29 日消息,据央视新闻一加一报道,国药集团中国生物首席科学家张云涛表示,"中国生物针对奥密克戎灭活疫苗什么时候能够上市,取决于我们的临床研究速度,就是安全性、有效性获得的速度,临床',
'inputtime' => '1651774789',
'updatetime' => '1651774789',
'thumb' => NULL,
'url' => '/youxi-48829',
'tags' =>
array (
0 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
1 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
2 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
3 =>
array (
'key' => '云涛',
'url' => 'https://www.dh3g.com/s-云涛',
),
4 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
5 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
6 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
7 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
8 =>
array (
'key' => '免疫',
'url' => 'https://www.dh3g.com/s-免疫',
),
9 =>
array (
'key' => '人群',
'url' => 'https://www.dh3g.com/s-人群',
),
10 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
11 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
12 =>
array (
'key' => '原型',
'url' => 'https://www.dh3g.com/s-原型',
),
13 =>
array (
'key' => '速度',
'url' => 'https://www.dh3g.com/s-速度',
),
14 =>
array (
'key' => '国药',
'url' => 'https://www.dh3g.com/s-国药',
),
15 =>
array (
'key' => '我国',
'url' => 'https://www.dh3g.com/s-我国',
),
16 =>
array (
'key' => '效果',
'url' => 'https://www.dh3g.com/s-效果',
),
17 =>
array (
'key' => '活性',
'url' => 'https://www.dh3g.com/s-活性',
),
18 =>
array (
'key' => '群体',
'url' => 'https://www.dh3g.com/s-群体',
),
19 =>
array (
'key' => '保护',
'url' => 'https://www.dh3g.com/s-保护',
),
),
),
9 =>
array (
'id' => '49680',
'title' => '中国生物:三款奥密克戎株新冠疫苗阿联酋获批临床',
'keywords' => '研究,生物,临床,试验,疫苗,中国,活疫苗,阿联酋,免疫,奥密,卫生,安全,生物制品,人群,以下简称,全球,制品,变异,国药,安全性',
'description' => 'IT之家 5 月 2 日消息,近期中国生物宣布,国药集团中国生物北京生物制品研究所、武汉生物制品研究所两款奥密克戎变异株(以下简称"奥株")灭活疫苗,国药中生生物技术研究院 / 新型疫苗国家工程研究中',
'catid' => '7',
'title_highlight' => '中国生物:三款奥密克戎株新冠疫苗阿联酋获批临床',
'content' => '...共计三款奥株新冠疫苗获阿联酋阿布扎比卫生部临床试验<em>批件</em>。这是中国生物奥株新冠疫苗全球多中心临床试验的重要进展。阿联酋阿布扎比卫生部批准的临床研究为序贯免疫临床研究,将采取随机、双盲、对照研究的形式开展...',
'keywords_highlight' => '研究,生物,临床,试验,疫苗,中国,活疫苗,阿联酋,免疫,奥密,卫生,安全,生物制品,人群,以下简称,全球,制品,变异,国药,安全性',
'description_highlight' => 'IT之家 5 月 2 日消息,近期中国生物宣布,国药集团中国生物北京生物制品研究所、武汉生物制品研究所两款奥密克戎变异株(以下简称"奥株")灭活疫苗,国药中生生物技术研究院 / 新型疫苗国家工程研究中',
'inputtime' => '1651775029',
'updatetime' => '1651775029',
'thumb' => NULL,
'url' => '/youxi-49680',
'tags' =>
array (
0 =>
array (
'key' => '研究',
'url' => 'https://www.dh3g.com/s-研究',
),
1 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
2 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
3 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
4 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
5 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
6 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
7 =>
array (
'key' => '阿联酋',
'url' => 'https://www.dh3g.com/s-阿联酋',
),
8 =>
array (
'key' => '免疫',
'url' => 'https://www.dh3g.com/s-免疫',
),
9 =>
array (
'key' => '奥密',
'url' => 'https://www.dh3g.com/s-奥密',
),
10 =>
array (
'key' => '卫生',
'url' => 'https://www.dh3g.com/s-卫生',
),
11 =>
array (
'key' => '安全',
'url' => 'https://www.dh3g.com/s-安全',
),
12 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
13 =>
array (
'key' => '人群',
'url' => 'https://www.dh3g.com/s-人群',
),
14 =>
array (
'key' => '以下简称',
'url' => 'https://www.dh3g.com/s-以下简称',
),
15 =>
array (
'key' => '全球',
'url' => 'https://www.dh3g.com/s-全球',
),
16 =>
array (
'key' => '制品',
'url' => 'https://www.dh3g.com/s-制品',
),
17 =>
array (
'key' => '变异',
'url' => 'https://www.dh3g.com/s-变异',
),
18 =>
array (
'key' => '国药',
'url' => 'https://www.dh3g.com/s-国药',
),
19 =>
array (
'key' => '安全性',
'url' => 'https://www.dh3g.com/s-安全性',
),
),
),
10 =>
array (
'id' => '110200',
'title' => '国产 mRNA 新冠疫苗 I 期临床数据超预期',
'keywords' => '疫苗,临床,试验,中国,生物,国产,剂量,成人,我国,中国澳门,之家,抗体,政府,病毒,结果,中国香港,澳门,香港,开发,中科院',
'description' => 'IT之家 1 月 9 日消息,虽然目前政府尚未批准任何一款国产 mRNA 上市,但实际上我国在这一领域的研究工作已有深入进展。据新浪,由艾美疫苗 / 丽凡达生物自研的 mRNA 新冠疫苗 I 期临床结',
'catid' => '7',
'title_highlight' => '国产 mRNA 新冠疫苗 I 期临床数据超预期',
'content' => '... mRNA 新冠疫苗获得国家药监局核准签发的《药物临床试验<em>批件</em>》,按计划启动临床试验。除此之外,我国国产 mRNA 新冠疫苗研发方面也有其他几个企业建树。例如军事科学院、艾博生物与沃森生物合作开发的 mRNA 新冠疫苗于 2020 ...',
'keywords_highlight' => '疫苗,临床,试验,中国,生物,国产,剂量,成人,我国,中国澳门,之家,抗体,政府,病毒,结果,中国香港,澳门,香港,开发,中科院',
'description_highlight' => 'IT之家 1 月 9 日消息,虽然目前政府尚未批准任何一款国产 mRNA 上市,但实际上我国在这一领域的研究工作已有深入进展。据新浪,由艾美疫苗 / 丽凡达生物自研的 mRNA 新冠疫苗 I 期临床结',
'inputtime' => '1651823314',
'updatetime' => '1651823314',
'thumb' => NULL,
'url' => '/youxi-110200',
'tags' =>
array (
0 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
1 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
2 =>
array (
'key' => '试验',
'url' => 'https://www.dh3g.com/s-试验',
),
3 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
4 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
5 =>
array (
'key' => '国产',
'url' => 'https://www.dh3g.com/s-国产',
),
6 =>
array (
'key' => '剂量',
'url' => 'https://www.dh3g.com/s-剂量',
),
7 =>
array (
'key' => '成人',
'url' => 'https://www.dh3g.com/s-成人',
),
8 =>
array (
'key' => '我国',
'url' => 'https://www.dh3g.com/s-我国',
),
9 =>
array (
'key' => '中国澳门',
'url' => 'https://www.dh3g.com/s-中国澳门',
),
10 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
11 =>
array (
'key' => '抗体',
'url' => 'https://www.dh3g.com/s-抗体',
),
12 =>
array (
'key' => '政府',
'url' => 'https://www.dh3g.com/s-政府',
),
13 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
14 =>
array (
'key' => '结果',
'url' => 'https://www.dh3g.com/s-结果',
),
15 =>
array (
'key' => '中国香港',
'url' => 'https://www.dh3g.com/s-中国香港',
),
16 =>
array (
'key' => '澳门',
'url' => 'https://www.dh3g.com/s-澳门',
),
17 =>
array (
'key' => '香港',
'url' => 'https://www.dh3g.com/s-香港',
),
18 =>
array (
'key' => '开发',
'url' => 'https://www.dh3g.com/s-开发',
),
19 =>
array (
'key' => '中科院',
'url' => 'https://www.dh3g.com/s-中科院',
),
),
),
11 =>
array (
'id' => '102646',
'title' => '脑机接口平台公司宁矩科技完成亿元 A 轮融资,自研系统级芯片已完成流片',
'keywords' => '接口,设备,芯片,医疗,公司,科研,平台,融资,系统,市场,无线,材料,专用,复杂,神经系统,一代,上千,下一代,中长期,人机',
'description' => '近日,侵入式脑机接口平台公司宁矩科技(NeuraMatrix)完成亿元 A 轮融资。据悉,本轮融资由华盖资本、沙特阿美旗下多元化风投基金 Prosperity7 Ventures(P7)联合领投,此轮',
'catid' => '7',
'title_highlight' => '脑机接口平台公司宁矩科技完成亿元 A 轮融资,自研系统级芯片已完成流片',
'content' => '...车间,也计划年内投入使用,将用于二类、三类医疗器械<em>批件</em>的注册申请。按照中长期规划,NeuraMatrix 将逐步打开下一代神经系统疾病医疗市场和互融式人机交互市场。',
'keywords_highlight' => '接口,设备,芯片,医疗,公司,科研,平台,融资,系统,市场,无线,材料,专用,复杂,神经系统,一代,上千,下一代,中长期,人机',
'description_highlight' => '近日,侵入式脑机接口平台公司宁矩科技(NeuraMatrix)完成亿元 A 轮融资。据悉,本轮融资由华盖资本、沙特阿美旗下多元化风投基金 Prosperity7 Ventures(P7)联合领投,此轮',
'inputtime' => '1651819090',
'updatetime' => '1651819090',
'thumb' => NULL,
'url' => '/youxi-102646',
'tags' =>
array (
0 =>
array (
'key' => '接口',
'url' => 'https://www.dh3g.com/s-接口',
),
1 =>
array (
'key' => '设备',
'url' => 'https://www.dh3g.com/s-设备',
),
2 =>
array (
'key' => '芯片',
'url' => 'https://www.dh3g.com/s-芯片',
),
3 =>
array (
'key' => '医疗',
'url' => 'https://www.dh3g.com/s-医疗',
),
4 =>
array (
'key' => '公司',
'url' => 'https://www.dh3g.com/s-公司',
),
5 =>
array (
'key' => '科研',
'url' => 'https://www.dh3g.com/s-科研',
),
6 =>
array (
'key' => '平台',
'url' => 'https://www.dh3g.com/s-平台',
),
7 =>
array (
'key' => '融资',
'url' => 'https://www.dh3g.com/s-融资',
),
8 =>
array (
'key' => '系统',
'url' => 'https://www.dh3g.com/s-系统',
),
9 =>
array (
'key' => '市场',
'url' => 'https://www.dh3g.com/s-市场',
),
10 =>
array (
'key' => '无线',
'url' => 'https://www.dh3g.com/s-无线',
),
11 =>
array (
'key' => '材料',
'url' => 'https://www.dh3g.com/s-材料',
),
12 =>
array (
'key' => '专用',
'url' => 'https://www.dh3g.com/s-专用',
),
13 =>
array (
'key' => '复杂',
'url' => 'https://www.dh3g.com/s-复杂',
),
14 =>
array (
'key' => '神经系统',
'url' => 'https://www.dh3g.com/s-神经系统',
),
15 =>
array (
'key' => '一代',
'url' => 'https://www.dh3g.com/s-一代',
),
16 =>
array (
'key' => '上千',
'url' => 'https://www.dh3g.com/s-上千',
),
17 =>
array (
'key' => '下一代',
'url' => 'https://www.dh3g.com/s-下一代',
),
18 =>
array (
'key' => '中长期',
'url' => 'https://www.dh3g.com/s-中长期',
),
19 =>
array (
'key' => '人机',
'url' => 'https://www.dh3g.com/s-人机',
),
),
),
12 =>
array (
'id' => '87815',
'title' => '重磅:国药集团中国生物新冠肺炎特异性治疗药物获批临床,全球尚无同品种上市',
'keywords' => '免疫,生物,治疗,血浆,国药,药物,集团,中国,临床,球蛋白,疫苗,全球,肺炎,活疫苗,病毒,静注,特异性,健康,生物制品,之家',
'description' => 'IT之家 9 月 3 日消息 据国药集团官微,国药集团中国生物研制的静注 COVID-19 人免疫球蛋白(pH4)(以下简称"新冠特免")已于 8 日 30 日获得国家药品监督管理局颁发的《药物临床试',
'catid' => '7',
'title_highlight' => '重磅:国药集团中国生物新冠肺炎特异性治疗药物获批临床,全球尚无同品种上市',
'content' => '...8 日 30 日获得国家药品监督管理局颁发的《药物临床试验<em>批件</em>》,批准开展临床试验。▲ 图源:国药集团,下同据介绍,静注 COVID-19 人免疫球蛋白(pH4)是治疗用生物制品一类新药,为全球首款采用新冠灭活疫苗免疫后血浆制...',
'keywords_highlight' => '免疫,生物,治疗,血浆,国药,药物,集团,中国,临床,球蛋白,疫苗,全球,肺炎,活疫苗,病毒,静注,特异性,健康,生物制品,之家',
'description_highlight' => 'IT之家 9 月 3 日消息 据国药集团官微,国药集团中国生物研制的静注 COVID-19 人免疫球蛋白(pH4)(以下简称"新冠特免")已于 8 日 30 日获得国家药品监督管理局颁发的《药物临床试',
'inputtime' => '1651810783',
'updatetime' => '1651810783',
'thumb' => NULL,
'url' => '/youxi-87815',
'tags' =>
array (
0 =>
array (
'key' => '免疫',
'url' => 'https://www.dh3g.com/s-免疫',
),
1 =>
array (
'key' => '生物',
'url' => 'https://www.dh3g.com/s-生物',
),
2 =>
array (
'key' => '治疗',
'url' => 'https://www.dh3g.com/s-治疗',
),
3 =>
array (
'key' => '血浆',
'url' => 'https://www.dh3g.com/s-血浆',
),
4 =>
array (
'key' => '国药',
'url' => 'https://www.dh3g.com/s-国药',
),
5 =>
array (
'key' => '药物',
'url' => 'https://www.dh3g.com/s-药物',
),
6 =>
array (
'key' => '集团',
'url' => 'https://www.dh3g.com/s-集团',
),
7 =>
array (
'key' => '中国',
'url' => 'https://www.dh3g.com/s-中国',
),
8 =>
array (
'key' => '临床',
'url' => 'https://www.dh3g.com/s-临床',
),
9 =>
array (
'key' => '球蛋白',
'url' => 'https://www.dh3g.com/s-球蛋白',
),
10 =>
array (
'key' => '疫苗',
'url' => 'https://www.dh3g.com/s-疫苗',
),
11 =>
array (
'key' => '全球',
'url' => 'https://www.dh3g.com/s-全球',
),
12 =>
array (
'key' => '肺炎',
'url' => 'https://www.dh3g.com/s-肺炎',
),
13 =>
array (
'key' => '活疫苗',
'url' => 'https://www.dh3g.com/s-活疫苗',
),
14 =>
array (
'key' => '病毒',
'url' => 'https://www.dh3g.com/s-病毒',
),
15 =>
array (
'key' => '静注',
'url' => 'https://www.dh3g.com/s-静注',
),
16 =>
array (
'key' => '特异性',
'url' => 'https://www.dh3g.com/s-特异性',
),
17 =>
array (
'key' => '健康',
'url' => 'https://www.dh3g.com/s-健康',
),
18 =>
array (
'key' => '生物制品',
'url' => 'https://www.dh3g.com/s-生物制品',
),
19 =>
array (
'key' => '之家',
'url' => 'https://www.dh3g.com/s-之家',
),
),
),
),
) |
related |
array (
1 =>
array (
'id' => '1',
'pid' => '0',
'pids' => '0',
'name' => '手游',
'dirname' => 'show',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 1,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'html' => 0,
'urlrule' => 1,
),
'displayorder' => '0',
'acount' => '4732',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '1',
'catids' =>
array (
0 => '1',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-1',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
2 =>
array (
'id' => '2',
'pid' => '0',
'pids' => '0',
'name' => '游戏资讯',
'dirname' => 'record',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 2,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'html' => 0,
'urlrule' => 1,
),
'displayorder' => '0',
'acount' => '1972',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '2',
'catids' =>
array (
0 => '2',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-2',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
3 =>
array (
'id' => '3',
'pid' => '0',
'pids' => '0',
'name' => '游戏攻略',
'dirname' => 'movie',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 3,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'urlrule' => 1,
'html' => 0,
),
'displayorder' => '0',
'acount' => '8168',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '3',
'catids' =>
array (
0 => '3',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-3',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
4 =>
array (
'id' => '4',
'pid' => '0',
'pids' => '0',
'name' => '电视游戏',
'dirname' => 'tv',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 4,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'urlrule' => 1,
'html' => 0,
),
'displayorder' => '0',
'acount' => '0',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '4',
'catids' =>
array (
0 => '4',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-4',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
5 =>
array (
'id' => '5',
'pid' => '0',
'pids' => '0',
'name' => '单机游戏',
'dirname' => 'music',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 5,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'urlrule' => 1,
'html' => 0,
),
'displayorder' => '0',
'acount' => '35499',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '5',
'catids' =>
array (
0 => '5',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-5',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
6 =>
array (
'id' => '6',
'pid' => '0',
'pids' => '0',
'name' => '网络游戏',
'dirname' => 'cartoon',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 6,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'urlrule' => 1,
'html' => 0,
),
'displayorder' => '0',
'acount' => '18837',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '6',
'catids' =>
array (
0 => '6',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-6',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
7 =>
array (
'id' => '7',
'pid' => '0',
'pids' => '0',
'name' => '科技资讯',
'dirname' => 'keji',
'pdirname' => '',
'child' => 0,
'disabled' => '0',
'ismain' => '1',
'childids' => 7,
'thumb' => '',
'show' => '1',
'setting' =>
array (
'disabled' => '0',
'linkurl' => '',
'getchild' => '0',
'notedit' => '0',
'seo' =>
array (
),
'template' =>
array (
'pagesize' => '20',
'mpagesize' => '20',
'list' => 'list.html',
'category' => 'category.html',
'search' => 'search.html',
'show' => 'show.html',
),
'cat_field' => NULL,
'module_field' => NULL,
'html' => 0,
'urlrule' => 1,
),
'displayorder' => '0',
'acount' => '43426',
'mid' => 'article',
'pcatpost' => 1,
'topid' => '7',
'catids' =>
array (
0 => '7',
),
'is_post' => 1,
'tid' => 1,
'url' => 'https://www.dh3g.com/list-7',
'total' => '请使用count标签查询',
'field' =>
array (
),
),
) |